![]() |
The commencement ceremony of the mRNA vaccine industrialization base of Sinopharm's China National Biotech Group is held in Shanghai's Jiading district on Sept 25. [Photo/jiading.gov.cn] |
The commencement ceremony of the mRNA vaccine industrialization base of Sinopharm's China National Biotech Group was held in Shanghai's Jiading district on Sept 25.
With a total construction area of 3.25 hectares, the industrialization base will research, develop and industrialize vaccines for COVID-19 variants.
More than 1.6 hectares of the construction area will be used for a production workshop, which is expected to become a domestically leading mRNA vaccine production workshop in terms of production capacity and technology.
The vaccine industrialization base will become a modern and low-carbon intelligent industrialization base that meets the requirements of biomedicine automation, informatization, intelligence, and internationalization.
![]() |
The total construction area of the industrialization base is 3.25 hectares, of which more than 1.6 hectares will be used for the production workshop. [Photo/jiading.gov.cn] |